Skip to main content
    Educational content — not medical advice. Information on this page is for educational purposes only and is not a substitute for advice from a licensed physician. GLP-1 medications carry meaningful risks; speak with your doctor before starting any treatment. Compounded GLP-1 medications are not FDA-approved and clinical evidence is less robust than for FDA-approved branded products (Wegovy, Zepbound, Ozempic, Mounjaro). Read our full medical disclaimer · FDA on compounded GLP-1.
    Fat Loss

    AOD-9604Anti-Obesity Drug 9604

    The "fat fragment" peptide — marketed as targeted lipolysis without muscle loss, but the evidence is weak and clinical trials failed.

    How this page is reviewed

    Editorially reviewed by GLP1CompareHub Editorial Team. We are an independent affiliate publisher — we are not licensed medical providers and this site does not deliver medical advice. Every claim on this page is sourced to a verifiable origin (peer-reviewed study, FDA documentation, live brand-site crawl, or our Katalys partner dashboard).

    Last editorially reviewed
    Invalid Date

    Affiliate disclosure: We earn a commission when you sign up with a provider through our links — at no extra cost to you. We do not rank providers by what they pay us; we rank by patient fit. Full disclosure. Read our methodology · medical disclaimer.

    If you are considering a GLP-1 medication: consult a licensed physician familiar with your medical history. Do not start, stop, or change a prescription based on content from this site. Side effects, contraindications, and drug interactions are real and individual.

    What It Is

    AOD-9604 is a 16-amino-acid fragment of human growth hormone (residues 177-191). It was originally developed as an anti-obesity drug claiming to produce targeted fat loss without the broader effects of full HGH. Clinical trials failed and the manufacturer abandoned development. It now exists primarily as a peptide-clinic offering.

    Mechanism

    Designed to mimic the lipolytic (fat-burning) portion of growth hormone without affecting glucose or growth. In theory, this would produce targeted lipolysis (especially of visceral and abdominal fat) without HGH side effects.

    What Consumers Use It For

    • Stubborn visceral or abdominal fat (especially when GLP-1 users hit a plateau)
    • Body recomposition without muscle loss claims
    • Used as an "add-on" to GLP-1 therapy in some peptide-clinic protocols

    Legal & Regulatory Status (May 2026)

    Reclassified after Category 2 list updates and now offered via licensed telehealth longevity clinics with prescription. Not FDA-approved for any use; the manufacturer abandoned development after failed obesity trials.

    Telehealth Providers & Pricing

    Verified May 2026. Pricing varies by dose, plan length, and bundling. Always confirm directly with the provider before signup.

    Telehealth longevity clinics (general)

    $150-$400/mo as add-on; often bundled lower

    What the Evidence Actually Shows

    Early obesity trials showed modest fat reduction but failed to meet endpoints. The manufacturer (Metabolic Pharmaceuticals) abandoned development around 2007. No strong human data has emerged since beyond small studies. The marketing significantly outpaces the clinical evidence — this is the weakest evidence base of the peptides on this list.

    Typical Dosing Protocol

    Typical consumer protocols: 250-500 mcg daily subcutaneous, often in the morning or pre-workout. Cycles of 8-12 weeks. Frequently bundled with other peptides (BPC-157, lipotropic injections) at peptide clinics.

    Dosing should be confirmed by your prescribing physician — these are common consumer protocols, not medical advice.

    What Real Users Report

    Synthesized from Reddit (r/Peptides, r/Semaglutide, r/Tirzepatide) and forums, May 2025-2026:

    Reddit reports are mixed-to-skeptical. Some users report subjective fat loss in target areas, but most acknowledge the effects are far less dramatic than GLP-1 medications alone. Users often describe AOD-9604 as an "optional plateau-buster" rather than a primary tool. Many reports suggest results are placebo or minor.

    Safety & Contraindications

    Generally well-tolerated in trials (one of its few proven properties). No major safety signals beyond standard injection-site reactions. The bigger concern is opportunity cost — money and effort spent on a poorly-evidenced peptide instead of optimizing your GLP-1 protocol.

    Best Reason to Add It

    May help with stubborn visceral fat once you have already optimized your GLP-1 dose and lifestyle. Best positioned as a low-priority experiment after the basics are dialed.

    Biggest Red Flag

    Weak clinical evidence and abandoned-by-manufacturer status. Marketing significantly outpaces the data. For most users, the money is better spent on a higher GLP-1 dose, better protein intake, or resistance training than on AOD-9604.

    Stacking note: Peptides are typically considered after a GLP-1 protocol is dialed in. If you have not started GLP-1 therapy yet, optimize that first. Compare GLP-1 telehealth pricing here before adding peptide protocols.

    Other Peptides for GLP-1 Stackers

    glp1comparehub

    Your independent guide to comparing GLP-1 medication providers. Find the right telehealth program for your weight-loss journey.

    Independent & Unbiased

    Medical Disclaimer: The information on this website is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any medication or treatment program. GLP-1 medications require a prescription and should only be used under medical supervision.

    Affiliate Disclosure: GLP1CompareHub.com is an independent review site. We may earn a commission when you click our links — at no additional cost to you. Our editorial recommendations are not influenced by commission rates. See our full affiliate disclosure.

    Compounded GLP-1 Notice: Compounded medications (compounded semaglutide, compounded tirzepatide) are NOT FDA-approved. They are produced by state-licensed 503A and 503B compounding pharmacies under specific FDA exemptions. Consult your prescriber about whether a branded FDA-approved medication or a compounded alternative is right for you.

    © 2026 GLP1CompareHub.com. All rights reserved.

    AOD-9604 2026: Evidence, Dosing, Cost & GLP-1 Stacking Guide | GLP1CompareHub